Brief: Allergy Therapeutics Posts H1 Net Income GBP -11.085 Million
31/03/2025 07:35
Mar 31 (Reuters) - Allergy Therapeutics H1 net income GBP -11.085 million. H1 gross profit GBP 20.862 million H1 EBIT GBP -8.612 million H1 pretax profit GBP -11.362 million
Recent news on Allergy Therapeutics
See all newsBrief: Allergy Therapeutics Expects FY 2026 Revenue Of £59.90 Million, Up 9% Reported
UK's Allergy Therapeutics FY revenue beats on Grassmuno launch
Allergy Therapeutics - Trading update for the year ended 30 June 2026
Brief: Allergy Therapeutics Appoints Helge Weiner-Trapness As Executive Chairman
Allergy Therapeutics - Appointment of Executive Chairman